CareLit · DOI-Nachweis · Gesundheitsökonomie & Qualitätsmanagement
The treatment of migraine patients with triptans – is there a need for further Rx-to-OTC switches?
DOI 10.1055/a-0836-2852
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN.N.
ZeitschriftGesundheitsökonomie & Qualitätsmanagement
Ausgabe1/2019
Jahrgang / SeitenJg. 19 · S. 15 bis 23
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Objective The disease migraine affects a large share of the German population and is linked to a high economic potential in terms of direct and indirect sickness costs. Triptans are the recommended treatment in the case of an acute migraine attack. Both, the disease and its appropriate treatment are of interest in the context of self-medication and Rx-to-OTC switch efforts. Therefore, a survey was carried o…
Zitieren
Zitierempfehlung
N.N (2019) The treatment of migraine patients with triptans – is there a need for further Rx-to-OTC switches?. Gesundheitsökonomie & Qualitätsmanagement, 19 (1), 15 bis 23. https://doi.org/10.1055/a-0836-2852
Mit CareLit weiterarbeiten